|4Feb 27, 3:34 PM ET

Gaines Kristin Sallee 4

4 · NATIONAL HEALTH INVESTORS INC · Filed Feb 27, 2024

Insider Transaction Report

Form 4
Period: 2024-02-23
Gaines Kristin Sallee
SVP/Chief Transaction Officer
Transactions
  • Award

    Common Stock

    2024-02-23+3,00051,609 total
  • Award

    Stock Option (Right to Buy) 2024

    2024-02-23+8,3338,333 total
    Exercise: $57.76From: 2024-02-23Exp: 2029-02-23Common Stock (8,333 underlying)
  • Award

    Stock Option (Right to Buy) 2024

    2024-02-23+8,3338,333 total
    Exercise: $57.76From: 2025-02-23Exp: 2029-02-23Common Stock (8,333 underlying)
  • Award

    Stock Option (Right to Buy) 2024

    2024-02-23+8,3348,334 total
    Exercise: $57.76From: 2026-02-23Exp: 2029-02-23Common Stock (8,334 underlying)
Holdings
  • Stock Option (Right to buy) 2022

    Exercise: $53.41From: 2024-02-25Exp: 2027-02-25Common Stock (18,334 underlying)
    18,334
  • Stock Option (Right to Buy) 2023

    Exercise: $54.73From: 2023-02-24Exp: 2028-02-24Common Stock (8,333 underlying)
    8,333
  • Stock Option (Right to Buy) 2023

    Exercise: $54.73From: 2024-02-24Exp: 2028-02-24Common Stock (8,333 underlying)
    8,333
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2020-02-21Exp: 2025-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2021-02-21Exp: 2025-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2022-02-21Exp: 2025-02-21Common Stock (18,334 underlying)
    18,334
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2021-02-25Exp: 2026-02-25Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2022-02-25Exp: 2026-02-25Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-25-2021

    Exercise: $69.20From: 2023-02-25Exp: 2026-02-25Common Stock (18,334 underlying)
    18,334
  • Stock Option (Right to buy) 2022

    Exercise: $53.41From: 2022-02-25Exp: 2027-02-25Common Stock (18,333 underlying)
    18,333
  • Stock Option (Right to buy) 2022

    Exercise: $53.41From: 2023-02-25Exp: 2027-02-25Common Stock (18,333 underlying)
    18,333
  • Stock Option (Right to Buy) 2023

    Exercise: $54.73From: 2025-02-24Exp: 2028-02-24Common Stock (8,334 underlying)
    8,334
Footnotes (1)
  • [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting February 23, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT